Cell death is a critical process that occurs normally in health and disease. However, its study is limited due to available technologies that only detect very late stages in the process or specific death mechanisms. Here, we report the development of a new fluorescent biosensor called genetically encoded death indicator (GEDI). GEDI specifically detects an intracellular Ca 2+ level that cells achieve early in the cell death process and marks a stage at which cells are irreversibly committed to die. The time-resolved nature of GEDI delineates a binary demarcation of cell life and death in real time, reformulating the definition of cell death. We demonstrate that GEDI acutely and accurately reports death of rodent and human neurons in vitro, and show GEDI enables a novel automated imaging platform for single cell detection of neuronal death in vivo in zebrafish larvae. With a quantitative pseudo-ratiometric signal, GEDI facilitates highthroughput analysis of cell death in time lapse imaging analysis, providing the necessary resolution and scale to identify early factors leading to cell death in studies of neurodegeneration.
Introduction
Neurodegenerative diseases such as Parkinson's disease (PD) 1,2 , Huntington's disease (HD) [3] [4] [5] [6] [7] , frontotemporal dementia (FTD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS) 8, 9 are characterized by progressive neuronal dysfunction and death, leading to deterioration of cognitive, behavioral or motor functions. In some cases, neuronal death itself is a better correlate of clinical symptoms than other pathological hallmarks of disease such as Lewy bodies in PD 10 , or b-Amyloid in AD 11 , and can be used to effectively characterize the relationship of an associated disease phenotype with degenerative pathology 12, 13 . Using neuronal death as a consistent and unequivocal endpoint, longitudinal single cell analysis can be performed on model systems to reveal the antecedents and forestallments of cell death 14, 15 .
Together with statistical tools used in clinical trials that account for variability, stochasticity and asynchronicity amongst individuals within a cohort, it is possible to regress premortem phenotypic markers of neurodegeneration 16 , determine which are beneficial, pathological, or incidental to degeneration, and quantify the magnitude of their contribution to fate. For instance, although inclusion body formation is a hallmark of disease in HD and Tar DNA binding protein -43 (TDP43) ALS, their presence appears to be more consistent with a coping mechanism rather than a causative factor, suggesting clinical intervention to inhibit inclusion body formation could be a misguided approach 3, 8 . While there is an ongoing debate about the relative contribution of neuronal dysfunction prior to neuronal death to the clinical deficits that patients exhibit, it is clear that neuronal death marks an irreversible step in neurodegenerative disease. Thus, neuronal death is an important, disease-relevant phenotypic endpoint that is important to understanding neurodegeneration, characterizing the mechanisms of neurodegenerative disease, and developing novel therapeutics.
Nevertheless, precisely determining whether a particular neuron is alive, dead or dying can be challenging, particularly in live imaging studies. Vital dyes, stains and indicators have been developed to selectively label live or dead cells and neurons in culture 17 , but the onset of these signals may be delayed until long after a neuron has shown obvious signs of degeneration 12 . Additionally, long-term exposure to exogenous dyes can increase the risk of accumulated exposure toxicity, negating their ability to non-invasively provide information on cell death. Many assays can distinguish between cell death pathways such as apoptosis or necrosis 13 and are conducive to longitudinal imaging 18, 19 , but these typically require a priori knowledge of which cell death pathway is relevant, limiting their utility in neurodegenerative disease, which often involves a spectrum of neuronal death mechanisms 20 . Moreover, cells that begin to die by one cell death pathway may resort to a different one if the original pathway is blocked 21 , which can confound analyses. Furthermore, the interpretation and accuracy of apoptotic markers can vary based on the specific cellular system, and some are associated with reversible processes, meaning multiple assays must be used in parallel to unambiguously characterize the precise extent of death within a sample 13, 21 . While defining the preferred cell death pathway can give insight into the underlying biology driving cell death, a cell-death pathway agnostic marker is necessary to give an unbiased and reliable readout. In live imaging experiments, the loss of fluorescence of transfected neurons, indicating the rupture of the plasma membrane, has been shown to clearly mark neuronal death 1, 3 , but fluorescent debris often persists for days after initial morphological signs of death and decay occur, limiting the ability to identify the precise time of death or introducing human error in the scoring of neuronal death by morphology 12 . In summary, without a strict criterion of what constitutes a "point of no return" at which a neuron's fate is unambiguously sealed, investigation of the causative factors that precede cell death remains challenging.
Although dyes have been used to detect neuronal death in vivo [22] [23] [24] , the permeability of dyes throughout tissue is inconsistent, making quantification difficult. Genetically encoded fluorescent proteins have greatly facilitated the ability to track single neurons within culture 3 and in tissue 25 over time. Furthermore, genetic targeting allows labeling of specific cell subtypes, as well as simultaneous expression of other biosensors, perturbagens, or activators 26 . Some of the most commonly used biosensors in neuroscience are the genetically-encoded Ca 2+ indicators (GECIs), including the yellow cameleons and GCaMPs/pericams 27, 28 . Based on the fusion of circularly permuted fluorescent proteins such as GFP with the Ca 2+ binding M13-calmodulin domain, GECIs are relatively bright biosensors with low toxicity in neurons 29 . GECIs are used to detect either relative or absolute Ca 2+ levels or neuronal circuit activity within neurons in culture 30 , in tissue 31 , within immobilized animals in virtual environments 32, 33 , and even within freely moving animals 34, 35 . The category of GECIs has been diversified and further optimized through the use of alternate fusion proteins to the M13-calmodulin domain as well as targeted mutagenesis 36, 37 . Recently, Suzuki et al. engineered endoplasmic reticulum (ER)-targeted calcium-measuring organelle-entrapped protein indicators (CEPIAer) variants that emit either green, red, or blue/green fluorescence to specifically detect Ca 2+ release events from the ER 37 . In contrast to previously developed ER Ca 2+ indicator dyes, CEPIAs and newly engineered derivatives 38 can be genetically and subcellularly targeted and are capable of long-term imaging over the lifetime of the neuron, enabling measurement of the full range of calcium dynamics within single neurons over time.
Here, we introduce a new class of GECIs for the detection of cell death in neurons that we call genetically encoded death indicators (GEDIs). We show that GEDIs can robustly indicate the moment when a neuron's ability to maintain Ca 2+ homeostasis is lost and cannot be restored, providing an earlier and more acute demarcation of the moment of death in a degenerating neuron than previously possible. In combination with a second fluorescent protein fused with a self-cleaving P2a peptide, pseudo-ratiometric GEDIs are easily quantifiable in high-throughput, give highly reproducible signal, and are amenable to long-term imaging. GEDIs can also be targeted to specific neuronal subtypes for imaging in vivo. These data establish GEDIs as important new tools for studying the time course of neurodegeneration, providing previously unobtainable delimitation and clarity to the time course of cell death.
Results

Development of genetically encoded death indicators
GECIs such as GCaMP6f have been engineered to increase in fluorescence in response to fluctuations in the range of cytosolic Ca 2+ concentrations that occur during neuronal firing ( Figure 1A ). The CEPIA GECIs have been engineered with elevated Kd to detect Ca 2+ transients in organelles such as the ER or mitochondria that contain higher Ca 2+ ( Figure 1A ) 37 . We reasoned that removing the ER retention signals and allowing CEPIA variants to localize to the cytosol would render a GECI that was not responsive to activity-based Ca 2+ transients, but that would increase in fluorescence intensity when cytosolic Ca 2+ levels approached those of intracellular organelles or the extracellular milieu, which would constitute a catastrophic event for the neuron. We named these reengineered indicators Genetically Encoded Death Indicators (GEDIs). In rat cortical primary neurons, a 10Hz field stimulation caused increased relative fluorescence within cells expressing GCaMP6f but not in those transfected with the red GEDI variant (RGEDI) ( Figure 1B -D). Addition of NaN3, which induces neuronal death, caused increased fluorescence in cells expressing either GCaMP6f or RGEDI (Figure 1B-D). The peak GCaMP6f fluorescence response after stimulation was nearly identical to the fluorescence response to NaN3 treatment; in contrast, the ratio of stimulation to death response in RGEDI expressing cells was close to 0, indicating that the RGEDI sensor preferentially responds to death ( Figure 1E ). Removal of extracellular Ca 2+ abrogated the fluorescence response to NaN3 treatment, indicating the primary increase in cytosolic Ca 2+ was due to influx from the extracellular space, rather than release from intracellular stores ( Supplementary Figure 1 ). To further optimize the RGEDI construct, we appended sequence encoding a porcine teschovirus-1 2a (P2a) "self-cleaving peptide" and EGFP, allowing normalization of the RGEDI signal to EGFP expression (GEDI ratio). This facilitated simple detection of the moment of neuronal death based on a cell's color change when the green and red channels are overlaid ( Figure 1F ,G).
To assess the ability of RGEDI to detect death in live cell imaging, we used automated longitudinal microscopy 3 to image individual neurons transfected with hSyn1:RGEDI-P2a-EGFP repeatedly at 3 hour intervals ( Figure 1H ,I). Neurons that died over the course of imaging were marked by clear fragmentation of morphology in the EGFP channel, followed by disappearance of the debris 3, 39, 40 . Once a cell died, the increase in GEDI ratio remained stable over the course of imaging until disappearance of the debris ( Figure 1H ,I). In some cases, an increase in GEDI ratio preceded obvious morphology changes ( Figure 1H ). GEDI signal correlated with and often preceded standard markers for neuronal death such as TUNEL 54 , ethidium homodimer D1 (EthD1) 41 , propidium iodide (PI) 42 , or human curation of the morphology 3 (Supplementary Figure 2 ). Due to the large separation of GEDI ratio between live and dead neurons, we established a formal threshold of death for the GEDI ratio that could be used to quantify the amount of cell death in high throughput. Rat primary cortical neurons were transfected with hSyn1:RGEDI-P2a-EGFP in a 96-well plate and the GEDI ratio was derived from each well before and after a subset was exposed to a known cytotoxin, NaN3 ( Figure 1J ). After 5 minutes, all neurons exposed to NaN3 showed increased GEDI ratio compared to neurons before treatment and those not exposed to NaN3 ( Figure 1J ). From these data, a GEDI ratio corresponding to the threshold of death (GEDI threshold) was calculated according to equation (1) (See methods).
Automated microscopy was then performed at 24 hour intervals for four days on the remaining 94 wells of the plate, and the previously derived GEDI threshold was used to assess the spontaneous neuronal death of hSyn1:RGEDI-P2a-EGFP-transfected neurons ( Figure 1K ). In parallel, neuronal death was assessed by manual curation based on the abrupt loss of neuronal fluorescence over time. All neurons identified as live by manual curation had a GEDI ratio below the GEDI threshold, and most neurons identified as dead by manual curation had a GEDI ratio above the GEDI threshold ( Figure 1K ). The few neurons classified as live by manual curation that contained a GEDI ratio above the threshold were recognized in hindsight to be difficult to classify based on morphology alone. Furthermore, each of these neurons could later be unequivocally classified as dead due to loss or fragmented pattern of fluorescence at the next imaged time point (Supplementary Figure 3A ), suggesting an error or inability of humans to correctly classify, and demonstrating GEDI is a more acute and accurate means of classifying neuronal death than manual curation. To examine the possibility that a temporarily increased GEDI ratio signal may give a false positive death indication, a large longitudinal data set of time lapse GEDI images containing 94,106 tracked neurons across multiple imaging conditions was generated ( Supplementary Table 1 ). Across all 32 longitudinal experiments, a consistent GEDI threshold indicating cell death could be established (Supplementary Figure 3B -C). Only 0.28% of all neurons exhibited a GEDI ratio above the threshold at one time point that subsequently decreased below the death threshold (Supplementary Figure 3D ). Upon closer examination of those 304 neurons, each was subsequently found to have an automated segmentation artifact, which distorted the ratio of RGEDI to GFP or a tracking artifact that confused objects, rather than decreased RGEDI signal in relation to GFP (Supplementary Figure 3E) . No neurons were found to "die twice," as would be indicated by two fluctuations in GEDI ratio above the death threshold. These data show that the GEDI signal is unlikely to increase above the GEDI threshold in a neuron that is not dead. Therefore, we conclude that GEDI is a biosensor that specifically signals an early and irreversible commitment to degeneration and death and can serve as a ground truth for quantifying cell death.
Automated identification of toxin resistant and sensitive subpopulations of neurons
We predicted that by combining GEDI and time lapse imaging, we would be able to monitor a heterogeneous death process and identify time-resolved subpopulations of neurons with differing sensitivities. Glutamate is the most common neurotransmitter in the brain 43 , but glutamate excess occurs in neurodegenerative disease and has been shown to be toxic to specific subpopulations of neurons 44 . Glutamate toxicity induces either apoptosis 44 or necrosis 45 , and a reliable death sensor capable of detecting either death type can facilitate an unbiased accounting of toxicity. In principle, GEDI should be able to detect all cell death events, as it detects loss of plasma membrane integrity rather than a specific substrate of a cell death pathway. To assess glutamate toxicity, rat primary neurons were transfected with hSyn1:RGEDI-P2a-EGFP and followed with automated microscopy after exposure to different levels of glutamate (Figure 2A It is known that GFP and RFP are differentially sensitive to lysosomal proteases, and that differential sensitivity has been exploited to develop tandem tag biosensors to measure autophagy 46 . Since Ca 2+ is known to activate certain proteases 47 , we wondered if differential degradation rates of RGEDI and EGFP fluorescence signals in dead neurons could cause the GEDI ratio to fluctuate and under-or overrepresent death. To investigate, we characterized the decay rate of EGFP and RGEDI signals after rapid death from glutamate toxicity. In dead neurons, the relative fluorescence of each protein decayed at equivalent rates (t1/2 = 20.45 hours RGEDI, 20.73 hours EGFP), indicating the activated GEDI ratio is a stable indicator of death across long time intervals of imaging during which neuronal debris remains present ( Figure 2E , F). These data suggest that GEDI is a powerful tool to accurately identify live neurons within a culture in which extensive death has occurred.
Automated survival analysis of multiple neurodegenerative disease models in different species with GEDI
Neurodegenerative disease-related neuronal death is associated with a spectrum of death mechanisms including apoptosis, necrosis, excitotoxicity, and autophagic cell death 20, 48 , necessitating the use of a death indicator of all types of cell death for effective and unbiased detection of total death. To test the effectiveness of GEDI across neurodegenerative disease models, hSyn1:RGEDI-P2a-EGFP was cotransfected into rat cortical primary neurons with pGW1:HttEx1-Q25 or pGW1:HttEx1-Q97, pCAGGs:α-synuclein, or pGW1:TDP43 to generate previously characterized overexpression models of HD 3 , PD 40 and ALS or frontotemporal dementia (FTD) 49 , respectively ( Figure 3A) . Each model has been associated with multiple types of cell death to varying degrees [50] [51] [52] [53] . In each model, neurons with characteristic yellow overlays of the RGEDI and EGFP channel could be detected at 24 hours ( Figure 3A -A''). GEDI ratios for neurons in each model and control at each time point were quantified, and a GEDI threshold was calculated using a subset of neurons designated dead or live by manual curation ( Figure 3A -B).
GEDI ratios from dead neurons in disease models were lower than GEDI ratios from controls, likely due to the combined effects of reduced total exogenous protein expression observed in each disease model compared to control, and lower separation of GEDI ratio between live and dead neurons at lower RGEDI-P2a-EGFP expression levels ( Supplementary Figure 4 ). High expression of GEDI likely correlates with high expression of co-transfected disease-causing protein, resulting in neurons with high exogenous protein expression levels to die and disappear sooner, causing underrepresentation of high expression of GEDI in disease models (Supplementary Figure 4 ). Nevertheless, a clear separation of live and dead neurons could still be observed in each case ( Figure 3B ). Using the labels generated from the GEDI threshold a cumulative risk-of-death (CRD), a statistical measure of survival used in clinical studies 54 , was generated showing significant toxicity of each model compared to controls as previously reported ( Figure 3C ). This showed that GEDI can be used to report toxicity over time across a variety of neurodegenerative disease models.
Cell-based overexpression models of neurodegeneration can be difficult to interpret because protein expression above physiological levels can introduce artifacts, which could also affect GEDI quantification. Neurons derived from induced pluripotent stem cells (iPSC) have the advantage of maintaining the genomic variants of the patients from whom the cells came, facilitating modeling of neurodegenerative diseases 55 . To test whether GEDI can detect death in an iPSC-derived model of neurodegeneration in which the endogenous disease-causing protein is expressed at physiologically relevant levels, motor neurons (MNs) were derived from iPSCs from normal control patients and compared to neurons derived from patients with a D90A SOD1 mutation, which has been shown to cause ALS 56 . iPSC MNs generated from patients fibroblasts that carry the D90A SOD1 mutation have been previously shown to model key pathologies associated with ALS, such as neurofilament containing inclusions and axonal degeneration, though a clear survival phenotype using a CRD to evaluate toxicity over time has not been established 57 . Neurons were transfected with hSyn1:RGEDI-P2a-EGFP after 19 days of differentiation, and imaged every 12 hours with automated microscopy ( Figure 3D -F). The GEDI ratio was quantified and a GEDI threshold was derived and used to generate a CRD plot, which showed that SOD1-D90A containing neurons exhibited increased risk of death compared to controls, with an CRD of 1.26 ( Figure 3G ). These data show that GEDI can be used to automatically detect neuronal death and derive CRDs from human neurons.
Development of an expanded family of GEDI sensors
To expand the applications of the GEDI biosensor, we tested other GEDI variants with alternative characteristics useful in different capacities. Reliance on green and red emission spectra for death detection with RGEDI-P2a-EGFP restricts the ability to concurrently image other biosensors whose spectra overlap, limiting the opportunity to investigate other co-variates of disease 14 . Accordingly, we engineered RGEDI-P2a-3xBFP, so that death can be reported during simultaneous imaging of green biosensors. Though the GEDI ratio derived from RGEDI-P2a-3´BFP has a smaller dynamic range due to the relative dimness of BFP, the rate of signal increase following exposure to NaN3 was not different between RGEDI-P2a-3´BFP and RGEDI-P2a-EGFP or GCaMP6f-P2a-mRuby 58 (GEDI ratio= GCaMP6f/mRuby) ( Figure 4A -D ANOVA p=0. 44 ).
Next, we tested a newly engineered ER Ca 2+ sensor based on the GCaMP GECI called GCaMP6-150, which was recently reported to have an excellent dynamic range 38 and higher affinity for Ca 2+ than RGEDI ( Figure 4E ). We generated a new GEDI sensor based on the GCaMP6-150 template by removing the ER signaling peptides from the GCaMP6-150 cassette and combining it with a P2a peptide and mApple to generate GC150-P2a-mApple. As expected, cells expressing GC150-P2a-mApple showed increased GEDI ratio (GEDI ratio=GC150/mApple) after NaN3-induced death ( Figure 4D -F).
GECIs targeted to the nucleus have been shown to increase resolution and duration of signal in whole brain studies of zebrafish 59 . Therefore, we generated GEDI constructs with nuclear localization signals (NLS): GC150-NLS-P2a-mApple-NLS and RGEDI-NLS-P2a-EGFP-NLS ( Figure 4F ,G). Each nuclear localized GEDI showed a similar increase in GEDI ratio upon NaN3 treatment, corresponding to the death of neurons ( Figure 4D ,G,H). The kinetics of the responses were not different between any of the GEDI variants (τ range= 4.7-6.4 minutes, ANOVA p=0.75), indicating similar ability to detect death across imaging situations in which different versions of GEDI are needed ( Figure 4D ). These data demonstrate that the GEDI approach offers an acute, versatile, and quantitative method to detect neuron death in time lapse imaging.
GCaMP acutely reports death in vivo
Many zebrafish larvae models of neurodegeneration have been developed, in part to take advantage of their unique characteristics, including translucent skin and the ability to be immobilized for long periods of time, that make them amenable to live imaging 60,61 . However, it has not been possible to acutely detect neuronal death and characterize the preceding events in vivo with time lapse imaging in these models, limiting the characterization of neuronal death to static snap shots of single time points [62] [63] [64] .
We sought to develop a platform to visualize neuronal death longitudinally in vivo with GEDI by adapting our automated 4-dimensional longitudinal single cell tracking microscopy platform 25 to in toto longitudinal imaging of live zebrafish larvae over multiple days (Supplementary Figure 5 ). Larvae at 72 hours post fertilization were anaesthetized in tricaine, immobilized in low melting point agarose in 96 well optical ZFplates (Diagnocine), where they can typically remain alive for 120 hours as assayed by heartbeat. Automated confocal microscopy was used to repeatedly image each fish in three dimensions at specified intervals, generating 4 dimensional (4D) images of each fish in an array (Supplementary Figure 5 ). To induce neuronal death, the inducible cell ablation protein nitroreductase (NTR) 65 was expressed in MNs using the mnx1 promoter 66 , and 10 µM of metronidazole (MTZ), a harmless prodrug that is activated by NTR, was added to the zebrafish media. By 24 hours after addition of MTZ, some motor neuron axons became clumped and motor neuron cell bodies looked fragmented compared to DMSO, yet no difference in motor neuron axon area was detected (Figure 5A-C). By 48 hours after addition of MTZ, motor neuron axons appeared to retract, and a reduction in axon area could be detected, yet somas and/or debris from the MNs remained in the spinal cord ( Figure   5A ,B). In contrast, non-immobilized mnx:Gal4; UAS:mCherry;UAS:EGFP zebrafish larvae became immotile upon incubation with MTZ for 24 hours, swimming no more than larvae in which the neuromuscular junction has been blocked with botulinum toxin (UAS:BoTx-EGFP) 67 ( Figure 5D ), indicating that 24 hours incubation in MTZ is sufficient to functionally ablate MNs.
Neuronal death at 24 hours post MTZ was also confirmed with the use of PhiPhiLux G1D2a live fluorescent reporter of caspase-3-like activity 23, 68 (Supplementary Figure 6A -C). These data suggest that an acute marker for neuronal death is required to monitor neurodegeneration in vivo that more accurately distinguishes live neurons from dead neurons.
GCaMP is commonly and widely used in zebrafish for studies of neuronal activity and functionality 69 , and transgenic lines with GCaMP expression in the nervous system are widely available, making it easy to apply to studies of neuronal death. GCaMP signal due to endogenous Ca 2+ transients in MNs is not distinguishable from signal due to loss of membrane integrity associated with neuronal death (see Figure 1 ). However, we found that GCaMP can be rendered a GEDI within the zebrafish by blocking endogenous neuronal activity with the use of tricaine, an anesthetic that blocks voltage-gated channels in the nervous system 70 even when the motor swimming circuit was activated by application of 0.1% Acetic Acid (AcOH), which stimulates swimming 71 ( Supplementary Figure 7A-B) . In contrast, with the use of a muscle contraction Supplementary Figure 8A-B) . Similarly, cacnb1 -/mutants, which are immobile due to loss of skeletal muscle function but maintain normal MN activity 73 , also showed increased GcaMP7 signal in response to MTZ treatment without tricaine immobilization (Supplementary Figure 8A-C) . Thus, GCaMP7 can be used as a GEDI and an accurate measure of neuronal death in immobilized zebrafish.
GEDI150 acutely reports death in vivo and is insensitive to Ca 2+ transients
Although GCaMP is effective at labeling neuronal death within tricaine-anaesthetized larvae, tricaine application can have adverse effects on physiology 74 , The dampening of neuronal activity within the zebrafish can potentially complicate the interpretation of neurodegenerative disease models, especially those in which hyperexcitibility is thought to be a disease-associated phenotype such as AD, FTD and ALS 75, 76 . Thus, a true GEDI would be preferable to GCaMP because it would eliminate the need for immobilization in zebrafish imaging preparations in which CNS activity is preserved, such as fictive swimming assays 72, 73, 77 .
We first tested the ability of RGEDI-P2a-EGFP to detect neuronal death in vivo by co-injecting DNA encoding neuroD:NTR-BFP and neuroD:RGEDI-P2a-EGFP at the 1-cell stage, and then using in toto live longitudinal imaging to track fluorescence of co-expressing neurons within the larval spinal cord after NTR-MTZ mediated ablation beginning at 72hpf ( Figure 6A ). After 24 hours of incubation in 10 µM MTZ, the morphology of neurons showed signs of degeneration including neurite retraction and loss of fluorescence, yet neurons co-expressing NTR-BFP and RGEDI-P2a-EGFP did not show increases in GEDI ratio ( Figure 6B,C) , indicating RGEDI signal cannot distinguish live from dead neurons in this system.
We hypothesized that extracellular Ca 2+ levels in vivo within the zebrafish larvae could be too low to reach the concentration required for RGEDI to optimally fluoresce. Therefore, we next tested if GC150, which has a higher binding affinity for Ca 2+ (Figure 4E ), could better report neuronal death in vivo. Sporadic expression of GC150-P2a-mApple was generated by coinjection of DNA encoding neuroD: GC150-P2a-mApple with neuroD:NTR-BFP at the 1-cell stage. Live longitudinal imaging was performed on larvae incubated in either DMSO or 10 µM MTZ, and individual neurons within the brain expressing both mApple and BFP were tracked in 4D within the whole larvae ( Figure 6D -F). Larvae exposed to 10 µM MTZ showed increased GC150 signal by 24 hours after MTZ extending to 48 hours, while larvae exposed to DMSO alone did not show signs of neuronal death or increases in GC150 ( Figure 6D -F). With increased binding affinity compared to RGEDI, GC150 could potentially be more susceptible to detecting physiological Ca 2+ transients within neurons, similar to GCaMP, which could confound its utility as a GEDI. To test whether GC150 increases in fluorescence during Ca 2+ transients, GC150 was targeted to MNs by injection of mnx1:GC150-P2a-mApple. Larvae were immobilized in BTS, and no response of GC150 was detected after activation of the motor circuit, indicating GC150 signal does not increase in response to normal calcium transients within neurons (Supplementary Figure 7F -G). These data indicate GC150 is suitable for in vivo detection of neuronal death in an un-anaesthetized animal.
Discussion
The study of neurodegenerative diseases has been hampered by an inability to distinguish populations of neurons destined to die from those that have already perished, which precludes the investigation of mechanisms that drive selective degeneration. Here, we characterize a novel biosensor GEDI, which is specifically tuned to detect neuronal death in longitudinal imaging studies, facilitating analysis of neurons in time points leading up to neuronal death. Using automated microscopy, we show that the analysis of GEDI is compatible with fully automated, single cell survival analysis, which has been previously shown to be 100-1000 times more sensitive than population-based studies that rely on a single snapshot in time 26 . We believe this tool will lead to more precision in discovery of the mechanisms of neurodegeneration and increase the throughput of quantitative studies to discover novel therapeutics.
Similar to other death-pathway agnostic indicators of cell death or viability, GEDI detects the loss of membrane integrity as a readout of cell death 78 Figure 2) . In contrast, each indicator we used to engineer GEDIs binds Ca 2+ in less than a second 37, 38, 79 , which is over 500× faster than the time course of death after NaN3 exposure ( Figure 4 ). GEDIs can also be combined with complementary labels specific for cell death pathways ( Supplementary Figure 2a) , which could help resolve ambiguity in cell death pathway crosstalk such as when a cell resorts to a different cell death pathway when the primary pathway is blocked 21 , by providing more direct temporal linkage between death pathway signal and death. The stability of the fluorescence tags used in the GEDIs (Figure 2D ), enables the signal to be sampled at long time intervals such as every 24 hours, a particularly important property during long-term imaging studies to minimize phototoxicity. These properties allowed us to use GEDIs to empirically determine the level of cytosolic Ca 2+ associated with an irreversible fate (Figure 1, Supplementary Figure 3 ), a property no other death indicator is capable of, to our knowledge. Furthermore, with the increased time resolution of death possible using GEDI, subpopulations of death-resistant neurons and the spread of neuronal death can now be imaged. For instance, reports of subpopulations of neurons displaying resistance to glutamate have been described in culture and in vivo [80] [81] [82] [83] , yet each report has relied on dyes to characterize death at static time points, limiting the ability to resolve the time coarse and cell-to-cell transmission of excitotoxic injury on a single cell level now possible with GEDI (Figure 2A-D) .
While this study focused on the use of GEDI in degenerating neurons, it should be noted that most if not all cells maintain a concentration gradient of Ca 2+ , suggesting that these death indicators could be adapted for use to report cell death and spread of cell death in other cell or tissue types 84 .
Although much of what we know about the etiology of neurodegenerative disease has come from 2-dimensional culture of neurons, it is becoming increasingly clear that the progression of neurodegenerative disease is dependent on the relationship of neurons to their surrounding tissue. For instance, multiple neurodegenerative diseases are linked to abnormal circuitry 75, 76, 85, 86 , and evidence suggests that propagation of neurodegenerative disease throughout the brain may proceed via the spread of pathogenic proteins [87] [88] [89] . To study such cell non-autonomous phenomena of neurodegeneration, an approach that integrates the 3dimensionality of tissue is required. Previously, we used organotypic slice culture to create a more tissue-like environment in which to study neurodegeneration over time, with an automated 4D imaging platform 90 . Here, in combination with GEDI, we apply this technology to a zebrafish model of neurodegeneration to study neuronal death in vivo. In contrast to organotypic slice culture models, which expose neurons to stresses of brain dissection and culturing, in vivo 4D imaging of zebrafish larvae fully preserves the architecture of the brain. Zebrafish larvae studies can also be scaled up for high-throughput imaging screens 91 , and to our knowledge our platform represents the first optimized for 4D longitudinal imaging of immobilized fish. This can be especially useful, as zebrafish larvae are a well characterized behavioral model 92, 93 , and 4D imaging can be used in parallel with behavioral analysis, providing an important behavioral correlate of neurodegeneration over time.
Our use of 4D imaging of zebrafish generated several important findings. First, we show that the loss of fluorescence is not an acute indicator of neuronal death in vivo ( Figure 5 ). One implication of this finding is that studies of neurodegeneration using fluorescent proteins in zebrafish could underestimate the time course of degeneration in the model, and behavioral characterization may be a more acute indicator of degeneration. Time lapse imaging of zebrafish neurodegeneration is also complicated by the species' high neuronal regeneration capacity 94 and the presence of scavenger cells such as microglia 62 , which could alter the apparent rate of death over time, underscoring the necessity of an acute indicator to track neurons as they die over time.
Second, our successful application of GCaMP7 to detect neuronal death in tricaine-immobilized zebrafish larvae means that commonly used GECIs, under neuronal paralytic conditions, can act as GEDIs. While GECIs prove to be a convenient tool for the study of neurodegeneration, this finding should also raise caution in the interpretation of GECI systems under conditions in which neuronal death occurs, as a chronic increase in GECI signal after death could be confused with normal Ca 2+ transient activity. Finally, we showed that although RGEDI construct could not be used to detect death in vivo, GC150 and GCaMP7 could. Due to the differences in Ca 2+ binding affinity between the three indicators, these data suggest that free Ca 2+ in the extracellular spaces in brain of the zebrafish larvae is somewhat limited and may be insufficient to induce the RGEDI fluorescence upon cell death. Thus, the difference in functionality of RGEDI in cultured neurons (Figures 1-4) and in vivo in the zebrafish brain ( Figures 5-6 ), could be due to the virtually unlimited supply of Ca 2+ in culture medium compared to the brain, where extracellular Ca 2+ can be limiting in times of high activity 95 and in dense synaptic areas 96 . Interestingly, the limited extracellular Ca 2+ in our in vivo assays raises the intriguing possibility that the sequestration of free calcium in debris of dead neurons could be a previously unexplored mechanism of cognitive decline in neurodegeneration. Future studies using 4D modeling will be key to address this question.
With few disease modifying therapies for neurodegenerative diseases available, there is a great need to understand disease mechanisms and etiology to develop new therapeutic targets 12 .
Our studies using neurodegenerative disease models of PD, ALS/FTD, Huntington's disease, glutamate toxicity, and in vivo neuronal ablation demonstrate the ability of GEDIs to acutely identify the moment of death in time lapse imaging studies, allowing a unique time-resolved view of neurodegeneration. We believe the use of GEDIs will aid longitudinal single cell analysis of neurons to complete our understanding of the underlying causes of neurodegeneration, and provide assays to help generate much needed therapeutics.
Methods
Animals and Culturing
All animal experiments complied with UCSF regulations. Primary mouse and rat cortical neurons were prepared at embryonic days 20-21 as previously described 97 . Neurons were plated in a 96 well plate at 0.1 × 10 6 cells per well and cultured in neurobasal growth medium with 100× GlutaMAX, Pen/Strep, and B27 supplement (NB medium). Zebrafish embryos raised to 48hpf were enzymatically dechorionated using 2mg/ml Pronase (Protease, Type XIV, Sigma) for 20 minutes. For behavioral analysis, embryos at 72 and 96 hpf were lightly tapped on the tail with #2 forceps while recording a 10s movie and analyzed as previously described 98 . A list of all zebrafish lines used in this study are available in Supplementary Table 2 .
Plasmids, Transfections, Toxins, Dyes and Injections
The mammalian expression constructs phSyn1:RGEDI-P2a-EGFP, phSyn1:RGEDI-P2a- Technologies) or 0.5uM propidium iodide (Life Technologies). Dyes were allowed to incubate for 30 minutes before a pretreatment timepoint was taken. Neurons were exposed to 90 seconds UV light with a custom-built LED light box to induce cell death and cells were imaged every 4 hours to track the signal of death indicators.
For field stimulation experiment primary mouse neurons were cultured for 4 days before transfection with phSyn1:RGEDI-P2a-EGFP or phSyn1:mRuby-P2a-GCaMP6f , and then imaged at 8 DIV in Tyrode's medium (pH 7.4; in mm: 127 NaCl, 10 HEPES-NaOH, 2.5 KCl, 2
MgCl2, and 2 CaCl2, 30 mm glucose and 10 mm pyruvate) using a Nikon CFI Plan Apo ×40/0.95 air objective on a Nikon Ti-E inverted microscope with an iXon EMCCD camera (Andor Technology). Field stimulation (3s*30Hz) was done after 7s of baseline recording using an A385 current isolator and a SYS-A310 Accu pulser signal generator (World Precision Instruments). 2% NaN3 was added by directly injecting into the imaging chamber after 30s to achieve immediate mixing. GCAMP6f and RGEDI fluorescence images were obtained using the To generate zebrafish constructs, gateway recombination-based cloning was performed (Life Technologies) using the Tol2kit 99 . A pME entry clone was generated for RGEDI-P2a3xBFP and RGEDI-P2a-EGFP by subcloning from phSyn1:RGEDI-P2a3xBFP, phSyn1:RGEDI-P2a-EGFP, or phSyn1:GCaMP6f-P2a-mRuby using the pCR8/GW/TOPO TA cloning kit (Life Technologies). pME:GC150-P2a-mApple, and pME-NTR-BFP were synthesized (Genscript) and cloned into pET-30a. Each was combined with p5E-neuroD 100 , P3E polyA and pDestTol2pA 99 , to generate neuroD: RGEDI-P2a-EGFP, neuroD: GC150-P2a-mApple and neuroD:NTR-BFP. Embryos were injected at 1-cell stage into the yolk with ~20nl containing 100ng/ul of each DNA. A list of all constructs used in this study are available in Supplementary Table 3 .
In toto automated 4D high content immobilized zebrafish imaging
For imaging experiments, zebrafish embryos were dechorionated at 24hpf, sorted for fluorescence, and put into 200 µM 1-phenyl 2-thiourea (PTU) E2 medium at 28.5°C to inhibit melanogenesis 101 . At 72hpf embryos were immobilized in 0.05% tricaine methanesulfonate (Sigma) or 50 µM BTS (Tocris) for an hour, then were loaded into wells of a ZFplate (Diagnocine) in 100ul of media with paralytic using wide bore tips and allowed to settle into the slits. Using a multichannel pipette, 100ul of molten 1.5% low melting point agarose was loaded into each nozzle hole, and then 100ul of agarose/paralytic mixture was immediately removed and agarose was allowed to solidify. Finally, liquid media was added to the top of each well containing paralytic with DMSO and/or with 10uM MTZ (Sigma).
The automated spinning disk confocal imaging system was previously described 25 .
Briefly, a custom system was used combining a Nikon microscope base (Nikon Ti-E), a Yokogawa spinning disk confocal (Yokogawa CSU-W1), an automated three axis stage (Applied Scientific Instrumentation, MS-2500-Ti and PZ-2300), and modified custom software allowing automated return to the same location on the imaging plate allowing continual imaging of the same location in 3D space. To accommodate zebrafish imaging at 28.5°C rather than at the enclosure temperature of 37°C for mammalian cell culture, a custom-made homeostatic peltier cooling lid was designed and constructed (Physiotemp) to sit on top of the ZF plate to maintain the temperature within the plate at 28.5 degrees.
Data analysis and quantification
Quantification of GEDI and morphology channel fluorescence intensity from 2D cultures was done using files obtained by automated imaging as previously described 3, 14, 102 . Files were processed using custom scripts running within a custom built image processing Galaxy bioinformatics cluster 25,103 that background subtracts, montages, fine tunes alignment across time points of imaging, segments individual neurons, tracks segmented neurons over time and then extracts intensity and feature information from each neuron into a csv file. Background subtraction was performed by subtracting the median intensity of each image, and was required for calculation of a translatable GEDI signal across data sets. Segmentation of neurons was targeted towards detection of the brightest area of the morphology of the neuron, usually the soma, that was larger than a minimal size threshold of 100 pixels. The GEDI ratio is sensitive to extent of segmentation of neurons, and errors in segmentation that include background can reduce the precision of the GEDI ratio obtained. A tight segmentation of neurons around the soma is desirable as segmentation of neurites frequently results in segmentation of multiple neurons at a time because of overlapping projections, and the dimmer and inconsistent morphology fluorescence signal extension throughout neurites. Tracking of neurons was performed by labeling an object as the same object at the next time point based on the proximity of the coordinates of the segmented mask to a segmented mask at the previous time point.
Survival analysis was performed by defining the time of death as the point at which the GEDI ratio of a longitudinally imaged neuron exceeds the empirically calculated GEDI threshold, or the point at which point a tracked segmentation label is lost, which was performed using custom scripts written in R. The GEDI threshold was determined using the following equation:
(1) GEDI ratio threshold= ([(mean GEDI ratio dead)-(mean GEDI ratio live)]*0.25) +
[mean GEDI ratio live]
The survival package for R statistical software was used to construct Kaplan-Meier curves from the survival data based on GEDI ratio, and survival functions were fit to these curves to derive cumulative survival and risk-of-death curves that describe the instantaneous risk of death for individual neurons as previously described 39 . Linear regressions of log decay and nonlinear regressions of GEDI signal increase were calculated in Prism using plateau followed by one phase association kinetics. 
